BCEIA 2023预登记通道：http://t2.eainfor.com/T/p/103_6
语言：英文
时间：2023年9月6日
地点：学术会议区W201
邀请全球知名科学家介绍DNA存储、纳米毒理学等前沿科学技术，分享球差电镜、微型化双光子显微镜等高端仪器的研究进展，同时就质谱法和核磁共振法等研究生物大分子结构及功能、新型分离介质制备及蛋白药物、疫苗纯化等最新应用进行探讨和展望。
报告题目：Analytical Strategies to Assess PFAS Removal and Lifecycle Fate during Adsorption or Transformative Water Treatment Processes
报告摘要
Per -and polyfluoroalkyl substances (PFAS) occur in ground and surface water sources across the globe, and proposed drinking water regulations are driving PFAS treatment technology development and implementation. This presentation will first address current treatment technologies, which utilize adsorption (liquid to solid phase transformation), membranes (liquid to liquid separations) or transformative (oxidation or reduction) processes. Examples will be provided how treatment process efficiencies for “real waters” and how the processes challenge analytical methods. Second, the presentation addresses end-of-life for residuals (e.g., activated carbon) that contains PFAS, which will require incineration. Tracking PFAS during incineration requires unique analytical approaches to track fluorinated aqueous, gaseous and solid-phase species. Overall, the presentation will demonstrate how to match PFAS analytical strategies to PFAS drinking water treatment processes.
个人简介
Dr. Paul Westerhoff is a Regents Professor and Fulton Chair of Environmental Engineering in the School of Sustainable Engineering and the Built Environment at Arizona State University. Since joining ASU he has held various administrative positions. After serving as the Civil and Environmental Engineering Department Chair he was the Founding Director for the School of Sustainable Engineering and the Built Environment, and served later as Associate & Vice Dean of Research in Engineering and ASU Vice Provost for Academic Programming. Dr. Westerhoff is the Deputy Director of a NSF ERC for Nanotechnology Enabled Water Treatment and co-Deputy Director of the NSF STC Science and Technologies for Phosphorus Sustainability Center. His research group addresses questions related to What pollutants exist in the environment? If they occur, do they matter? If they occur and matter, what do we do to address them? with a focus on pollutants in natural and engineered water systems. He has over 400 journal publications (H-index>100) and multiple patents. He is the recipient of the 2020 A.P. Black award, 2019 NWRI Clarke Prize, 2015 ASU Outstanding Doctoral Mentor, 2013 ARCADIS/AEESP Frontier in Research Award, and 2006 Paul L. Busch Award. He was elected to the National Academy of Engineering in 2023.
报告题目：False positive, negative, and unexpected Drug Testing Results in the Urine Toxicology Laboratory |药物测试：尿液毒理学实验室使用筛选法（免疫测定法）和确认法（MS）
报告摘要
In 1995 I co-authored a short article entitled “False-positive Immunoassay Results for Urine Benzodiazepine in Patients Receiving Oxaprozin (Daypro)”. This was published when rapid urine drug screening test methods were first becoming available. The laboratory community was starting to realize that not all assays can be tested for all of the thousands of drugs, substances or endogenous compounds that may potentially cause result errors.
There are false positive, false negative and unexpected patient urine drug test results that occur in the Urine Toxicology laboratory.
How does one research these results and assist the clinician in helping to assess these results to treat their patient?
Unexpected urine drug test results can occur during any phase of the testing process； however, the most common usual results occur during the pre -analytical or patient collection phase. During this phase patients can provide “fake” urine, take substances that can affect the testing method, or they can adulterate/dilute their urine specimen.
Depending on the screening test method used, the test method can be impacted by a variety of substances that can produce either false negative, false positive or usual results. Screening results can also be different than the confirmation results making interpretation of patient results even more confusing.
During this presentation we will review a basic screening test method and confirmation method. And discuss some of these unexpected urine drug test results.
个人简介
Paul Breitenbecher在罗得岛大学、康涅狄格大学、杜肯大学等高校进修了研究生课程，曾在哈佛先锋医学中心、诺华生物医学研究院、病理实验室公司（Inform Diagnostics，原名Miraca Life Sciences Inc.）等知名医学机构和企业的实验室从事管理工作。现任Breiten Associates LLC公司的首席执行官，为临床实验室和CRO领域的科研人员提供采购、咨询等方面的技术支持。
报告题目：Certified Reference Materials for a Global Greenhouse Gas Monitoring Infrastructure
报告摘要
Understanding sources and sinks of Greenhouse Gases (GHG) and the impact of policies to mitigate emissions provides a key tool for action against Climate Change. GHG emissions and uptake can be determined through measurement systems that include in situ measurement of GHG concentration at varying levels of spatial distribution. These measurements together with wind-speed measurements and numerical weather prediction and dispersion models can be used to determine spatially and time resolved GHG emissions and sinks. Maintaining a global system of such measurements, as envisaged, for example, by the WMO initiative on a coordinated global Greenhouse Gas Monitoring Infrastructure, requires close attention to quality assurance and equivalence of measurements from different sites. Significant emissions may lead to small changes in GHG concentration, requiring highly consistent calibration standards at different measurement sites. The presentation will cover the establishment and characterization of CO2 in air standards for the measurements of concentration as well as isotope ratio, for source apportionment, that are required in GHG measurement networks. Generating the highest precision measurements of CO2 in air requires adopting metrological traceability to defined sets of primary standards, the so-called scale approach. The conversion of CO2 in air amount fraction values from one scale to another requires the scale relationships to be well known, noting that the requirement for internal consistency of standards within a scale, such as the WMO-CO2-X2019 scale, is at the 0.01 μmol/mol level, and consistency between different scales should not exceed the 0.02 μmol/mol level [1]. Certified reference materials that are needed to calibrate both in-situ based optical/laser based GHG amount faction and isotope ratio measurements as well as mass spectrometric laboratory-based measurements of isotope ratio will be described, as well as on-going comparisons to verify their equivalence. These comparisons are supporting National
个人简介
Robert Wielgosz博士是位于法国的国际计量局（BIPM）化学部的主任，其气体计量实验室负责组织空气质量和温室气体标准国际比对。这些比对为由国家计量院（NMIs）和指定机构（DIs）组成的世全球大气监测网络提供标准支撑。他是国际计量委员会（CIPM）气候变化和环境领域任务组成员，也是国际计量局-世界气象组织（WMO）“气候行动中的计量”研讨会指导委员会主席。他发表测量科学相关论文60余篇，包括世界气象组织大气气体成分测量指南。他拥有剑桥大学伊曼纽尔学院（英国）的自然科学硕士学位，巴斯大学（英国）的博士学位，并在乌尔姆大学（德国）完成了皇家学会欧洲交流研究。
首页
